ICON Strategic Solutions in the news
FSP service provider
Tamtam found 3 recent articles about ICON Strategic Solutions.
- ICON (ICLR) Q2 2025 Earnings Call Transcript
ICON reported sequential revenue and booking growth in Q2 2025 while navigating elevated clinical trial cancellations and an increasingly competitive pricing environment.
- ICON tops list of most-used contract research organisations in 2024
ICON leads the 2024 contract research market with over 500 new clinical trials and a robust pipeline of upcoming projects in various therapeutic areas.
- LEO Pharma and ICON Enter Strategic Partnership
LEO Pharma and ICON formed a strategic partnership to improve clinical trial execution in medical dermatology through a hybrid outsourcing model.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like ICON Strategic Solutions?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies